Trials / Sponsors / BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations Parkinson Disease, Motor Disorder | Phase 2 | 2018-08-31 |
| Completed | BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2017-06-12 |
| Completed | A Study of LY2940094 in Participants With Alcohol Dependency Alcoholism | Phase 2 | 2013-07-01 |
| Completed | Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD) Major Depressive Disorder | Phase 2 | 2012-11-01 |
| Completed | A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects Depression | Phase 1 | 2011-07-01 |
| Completed | A Study of LY2940094 in Major Depressive Disorder Major Depressive Disorder | Phase 1 | 2010-12-01 |